Skip to main content
Terug
GPCR logo

Structure Therapeutics Inc.

Datakwaliteit: 100%
Oversold
GPCR
NASDAQ Healthcare Biotechnology
€ 49,06
▲ € 0,47 (0,97%)
Marktkapitalisatie: 2,82B
Dagbereik
€ 48,37 € 51,39
52-Weeksbereik
€ 13,22 € 94,90
Volume
1.411.445
50D / 200D Gem.
€ 71,72 / € 40,61
Vorige Slotkoers
€ 48,59

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -20,0 0,4
P/B 1,9 2,9
ROE % -11,9 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -225,81M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-11,86%
ROIC-14,16%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,00
Current Ratio24,81
Interest Coverage0,00

Waardering

P/E Ratio
-20,00
P/B Ratio1,86
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -141,20M
ROE -11,86% ROA -8,91%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -225,81M
ROIC -14,16% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 24,81
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -20,00 P/B Ratio 1,86
P/S Ratio N/A PEG Ratio -11,37
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 2,82B Enterprise Value 2,03B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -141,20M -122,53M -89,62M -51,32M -40,01M
EPS (Diluted) -2,40 -2,34 -2,43 -1,44 -1,20
Gross Profit -3,90M 0,0 0,0 0,0 0,0
Operating Income -287,57M -158,23M -102,78M -52,56M -37,70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,58B 903,33M 482,02M 97,85M 111,16M
Total Liabilities 67,54M 38,49M 29,05M 212,99M 175,89M
Shareholders' Equity 1,52B 864,84M 452,97M -115,14M -64,74M
Total Debt 6,49M 3,86M 5,45M 260.000,0 621.000,0
Cash & Equivalents 799,62M 169,51M 129,79M 26,09M 105,31M
Current Assets 1,57B 891,21M 473,61M 93,09M 109,25M
Current Liabilities 63,29M 36,02M 24,74M 13,01M 8,66M